Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples